Subsequently, a study has revealed the expression patterns of Fam20C in pan-cancer, of which increased expressions were correlated with poor prognosis in bladder urothelial carcinoma (BLCA), brain lower grade glioma (LGG), and stomach adenocarcinoma (STAD), making Fam20C a potential prognostic biomarker in those tumors. Here, FAM20C is linked to gastric adenocarcinoma.